This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: The Innovations of Timothy R Marr
Introduction
Timothy R Marr is a notable inventor based in Deruyter, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of AIDS. His innovative work has led to the development of a unique process that enhances the efficacy of a specific compound.
Latest Patents
Timothy R Marr holds 1 patent for his invention titled "d.sub.4 T polymorphic Form 1 process." This patent describes a novel process that utilizes controlled cooling to obtain d.sub.4 T polymorphic Form I from a mixture containing one or more of polymorphic Forms I, II, and III. The compound d.sub.4 T has been approved for use in the treatment of AIDS, showcasing the importance of his work in addressing critical health issues.
Career Highlights
Marr is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role in this organization has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise and innovative mindset have been instrumental in advancing the company's mission to discover, develop, and deliver innovative medicines.
Collaborations
Throughout his career, Timothy R Marr has collaborated with esteemed colleagues, including Murray A Kaplan and Robert K Perrone. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the pursuit of innovative solutions in the field of pharmaceuticals.
Conclusion
Timothy R Marr's contributions to the pharmaceutical industry, particularly through his patent for the d.sub.4 T polymorphic Form 1 process, highlight his role as an influential inventor. His work not only advances scientific knowledge but also plays a crucial role in improving health outcomes for individuals affected by AIDS.